Weekly Recap | Editas Medicine -16.41%, consensus target above spotWeekly Review·Sep 12 at 08:10 AMEDIT+4.98%
Weekly Recap | Caris Life Sciences -2.91%, most brokers rate it buyWeekly Review·Sep 12 at 07:49 AMCAI+10.60%
Weekly Recap | TScan Therapeutics -48.04%, reorganisation pivots to in vivo cell therapyWeekly Review·Sep 5 at 08:11 AMTCRX+4.14%
The Nasdaq Biotechnology Index rose over 2.1%Wallstreetcn·Nov 21, 2025 at 05:11 PMADPT+2.46%ZVRA+0.72%
The Nasdaq Biotechnology Index closed down 2%, with constituent stock UroGen Pharma down 44.70%, Lexeo Therapeutics down 13.31%, and Applied Therapeutics down 12.63%, the third largest decline. TScan Therapeutics rose 7.02%, ranking third in performance, Lexicon Pharma (LXRX) rose 7.65%, and Arcellx rose 8.11%Wallstreetcn·May 21, 2025 at 08:39 PMLXRX+0.50%TCRX+4.14%
